Fragile X Syndrome Study (RECONNECT)
The RECONNECT study is evaluating an investigational, topical gel to address behavioural issues related to Fragile X syndrome (FXS).
The trial is currently enrolling:
- people ages 3 to 22 with a genetic diagnosis of Fragile X syndrome
- who are experiencing behavioural symptoms
- and are in generally good health
Complete the form below to learn more and see if you or someone you love may be eligible to participate.